|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization of intangible assets | |||||
| Change in straight-line rent receivable | |||||
| Amortization of operating lease right-of-use asset | |||||
| Stock-based compensation and service expense | |||||
| Amortization of debt discount | |||||
| (Income) loss from equity method investment | |||||
| Impairment of equity method investment - Epicon | |||||
| Amortization of debt issuance costs and debt discount | |||||
| Distribution of earnings from equity method investment | |||||
| Change in fair market value of derivative liability | |||||
| Gain on debts extinguishment | |||||
| Impairment of laboratory equipment | |||||
| Debt modification charge | |||||
| Loss on extinguishment of debt | |||||
| Changes in operating assets and liabilities: | |||||
| Rent receivable | |||||
| Security deposit | |||||
| Deferred leasing costs | |||||
| Prepaid expense and other assets | |||||
| Accrued liabilities and other payables | |||||
| Accrued liabilities and other payables - related parties | |||||
| Operating lease obligation | |||||
| NET CASH USED IN OPERATING ACTIVITIES | |||||
| NET CASH USED IN OPERATING ACTIVITIES FROM CONTINUING OPERATIONS | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchase of property and equipment | |||||
| Payment for equity interest purchase | |||||
| NET CASH USED IN INVESTING ACTIVITIES | |||||
| Cash acquired on acquisition | |||||
| Proceeds from sale of equity method investment | |||||
| NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES FROM CONTINUING OPERATIONS | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from loan payable - related party | |||||
| Proceeds from issuance of convertible debt and warrants | |||||
| Proceeds from issuance of convertible debt | |||||
| Payments of convertible debt issuance costs | |||||
| Repayments of convertible debt | |||||
| Proceeds from issuance of balloon promissory note | |||||
| Payments of balloon promissory note issuance costs | |||||
| Repayments of loan payable - related party | |||||
| Proceeds from issuance of convertible debts and warrants | |||||
| Proceeds from stock subscription liability | |||||
| Advance from pending sale of noncontrolling interest in subsidiary | |||||
| Proceeds from issuance of convertible preferred stock | |||||
| Payments of convertible preferred stock issuance costs | |||||
| Proceeds from issuance of bridge loan | |||||
| Proceeds from equity offering | |||||
| Disbursements for equity offering costs | |||||
| NET CASH PROVIDED BY FINANCING ACTIVITIES FROM CONTINUING OPERATIONS | |||||
| DISCONTINUED OPERATIONS | |||||
| Net cash used in operating activities from discontinued operations | |||||
| Net cash used in investing activities from discontinued operations | |||||
| NET CASH FLOWS USED IN DISCONTINUED OPERATIONS | |||||
| EFFECT OF EXCHANGE RATE ON CASH - CONTINUING OPERATIONS | |||||
| NET (DECREASE) INCREASE IN CASH | |||||
| CASH - beginning of year | |||||
| CASH - end of year | |||||
| CASH - beginning of year | |||||
| CASH - end of year | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||
| Interest | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Reclassification of advances for equity interest purchase to equity method investment | |||||
| Series B Convertible Preferred Stock issued related to equity method investment | |||||
| Accrued purchase price related to equity method investment | |||||
| Warrants issued as convertible notes payable finder’s fee | |||||
| Warrants issued with convertible notes payable recorded as debt discount | |||||
| Common stock issued as convertible notes payable commitment fee | |||||
| Common stock issued for future services | |||||
| Common stock issued for accrued liabilities | |||||
| Receivable related to sale of equity method investment | |||||
| Related party payable extinguished upon sale of equity method investment | |||||
| Series B Convertible Preferred Stock extinguished related to sale of equity method investment | |||||
| Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock | |||||
| Warrants issued as convertible note payable finder's fee | |||||
| Warrants issued with convertible note payable recorded as debt discount | |||||
| Common stock issued as convertible note payable commitment fee | |||||
| Equity method investment payable paid by a related party | |||||
| Reclassification of deferred offering costs | |||||
| Settlement of derivative liability | |||||
| Issuance of common stock upon cashless exercise of stock warrants | |||||
| Initial ROU asset and lease liability | |||||
| Conversion of convertible note payable and accrued interest into common stock | |||||
| Deferred financing costs in accrued liabilities | |||||
| Legal fees recorded to receivable from sale of equity method investment | |||||
| Reclassification of related party loan payable and accrued expenses to advance from related party | |||||
| Shares issued for adjustments for 1:15 reverse split | |||||
| Bridge loan issuance costs in accrued liabilities | |||||
| Common stock issued as convertible note payable commitment fee included in accrued liabilities | |||||
Loading...